These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30831104)

  • 41. The influence of the levonorgestrel-releasing intrauterine system position on bleeding patterns in reproductive age women.
    Alves RDMS; Rabelo MM; Andrade VR; Cabral RCS; Merriman JW; Brito MB
    Int J Gynaecol Obstet; 2019 Dec; 147(3):326-331. PubMed ID: 31489621
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of a levonorgestrel-releasing intrauterine system on angiogenic growth factors in the endometrium.
    Roopa BA; Loganath A; Singh K
    Hum Reprod; 2003 Sep; 18(9):1809-19. PubMed ID: 12923132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of use.
    Gemzell-Danielsson K; Apter D; Dermout S; Faustmann T; Rosen K; Schmelter T; Merz M; Nelson A
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():22-28. PubMed ID: 27930941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D; Janssens D; Andrade A
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Levonorgestrel-releasing (20 microgram/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives.
    French RS; Cowan FM; Mansour D; Higgins JP; Robinson A; Procter T; Morris S; Guillebaud J
    BJOG; 2000 Oct; 107(10):1218-25. PubMed ID: 11028571
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
    Witjaksono J; Lau TM; Affandi B; Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 users.
    Backman T; Huhtala S; Blom T; Luoto R; Rauramo I; Koskenvuo M
    BJOG; 2000 Mar; 107(3):335-9. PubMed ID: 10740329
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selection and performance of the levonorgestrel-releasing intrauterine system.
    Lähteenmäki P; Bardin CW; Elomaa K; Haukkamaa M; Kivijärvi A; Kuukankorpi A; Venhola M; Tuominen J
    Acta Obstet Gynecol Scand Suppl; 1997; 164():69-74. PubMed ID: 9225643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endothelial function in women using levonorgestrel-releasing intrauterine system (LNG-IUS).
    Selim MF; Hussein AF
    Contraception; 2013 Apr; 87(4):396-403. PubMed ID: 23332246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of initial bleeding or spotting after levonorgestrel-releasing intrauterine system placement: a randomized controlled trial.
    Sørdal T; Inki P; Draeby J; O'Flynn M; Schmelter T
    Obstet Gynecol; 2013 May; 121(5):934-941. PubMed ID: 23635728
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
    Xiao B; Zeng T; Wu S; Sun H; Xiao N
    Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A single-arm phase III study exploring the efficacy and safety of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg), in an Asia-Pacific population.
    Fan G; Kang S; Ren M; Weisberg E; Lukkari-Lax E; Roth K; Shin S
    Contraception; 2017 Apr; 95(4):371-377. PubMed ID: 27913229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
    Sturridge F; Guillebaud J
    Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contraception and treatment in the perimenopause with a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: an extended pilot study.
    Wildemeersch D; Schacht E; Wildemeersch P
    Contraception; 2002 Aug; 66(2):93-9. PubMed ID: 12204781
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Timing of insertion affects expulsion in patients using the levonorgestrel 52 mg intrauterine system for noncontraceptive indications.
    Harris S; Kaneshiro B; Ahn HJ; Saito-Tom L
    Contraception; 2021 Mar; 103(3):185-189. PubMed ID: 33290726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of the Levonorgestrel Intrauterine System to Treat Heavy Menstrual Bleeding in Adolescents and Young Adults with Inherited Bleeding Disorders and Ehlers-Danlos Syndrome.
    Huguelet PS; Laurin JL; Thornhill D; Moyer G
    J Pediatr Adolesc Gynecol; 2022 Apr; 35(2):147-152.e1. PubMed ID: 34775059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Chin J; Konje JC; Hickey M
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5mg) in postmenarcheal adolescents.
    Gemzell-Danielsson K; Buhling KJ; Dermout SM; Lukkari-Lax E; Montegriffo E; Apter D
    Contraception; 2016 Jun; 93(6):507-12. PubMed ID: 26872720
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bleeding patterns for the Liletta
    Schreiber CA; Teal SB; Blumenthal PD; Keder LM; Olariu AI; Creinin MD
    Eur J Contracept Reprod Health Care; 2018 Apr; 23(2):116-120. PubMed ID: 29560743
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized controlled pilot study of ulipristal acetate for abnormal bleeding among women using the 52-mg levonorgestrel intrauterine system.
    Fava M; Peloggia A; Baccaro LF; Castro S; Carvalho N; Bahamondes L
    Int J Gynaecol Obstet; 2020 Apr; 149(1):10-15. PubMed ID: 31777949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.